Utility of intrathoracic impedance monitoring in pediatric and congenital heart disease

PACE - Pacing and Clinical Electrophysiology

Volumn 36, Issue 8, 2013, Pages 994-999

  LaPage, Martin J ^a   Von Alvensleben, Johannes ^a   Dick, Macdonald ^a   Serwer, Gerald ^a   Bradley, David J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

congestive heart failure; defibrillation ICD; electrophysiology clinical

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BIOLOGICAL MONITORING; CARDIOVASCULAR MONITORING DEVICE; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CONTROLLED STUDY; HEART VENTRICLE ARRHYTHMIA; HUMAN; IMPEDANCE; PREDICTIVE VALUE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD;

EID: 84880918761     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/pace.12134     Document Type: Article

References (22)

1. Wang L, Lahtinen S, Lentz L, Rakow N, Kaszas C, Ruetz L, Stylos L, et al. Feasibility of using an implantable system to measure thoracic congestion in an ambulatory chronic heart failure canine model. Pacing Clin Electrophysiol 2005; 28: 404-411. (Pubitemid 40696301)
2. Wang L,. Fundamentals of intrathoracic impedance monitoring in heart failure. Am J Cardiol 2007; 99: 3G-10G.
3. Medtronic Connect Website. https://wwwp.medtronic.com/mdtConnectPortal/ dynamicarea/optivolpredictsworseningheartfailure/1581802169585. Accessed September 16, 2012.
4. Yu C-M, Wang L, Chau E, Chan RH-W, Kong S-L, Tang M-O, Christensen J, et al. Intrathoracic impedence monitoring in patients with heart failure: Correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 2005; 112: 841-848. (Pubitemid 41170070)
5. Ypenburg C, Bax JJ, van der Wall EE, Schalij MJ, van Erven L,. Intrathoracic impedance monitoring to predict decompensated heart failure. Am J Cardiol 2007; 99: 554-557. (Pubitemid 46215562)
6. Vollmann D, Nagele H, Schauerte P, Weigand U, Butter C, Zanotto G, Quesada A, et al. Clinical utility of intrathoracic impedance monitoring to alert patients with an implanted device of deteriorating chronic heart failure. Eur Heart J 2007; 28: 1835-1840. (Pubitemid 47236638)
7. Maines M, Catanzariti D, Cemin C, Vaccarini C, Vergara G,. Usefulness of intrathoracic fluids accumulation monitoring with an implantable biventricular defibrillator in reducing hospitalizations in patients with heart failure: A case-control study. J Interv Card Electrophysiol 2007; 19: 201-207. (Pubitemid 47573216)
8. Catanzariti D, Lunati M, Landolina M, Zanotto G, Lonardi G, Iacopino S, Oliva F, et al. Monitoring intrathoracici impedance with an implantable defibrillator reduces hospitalizations in patients with heart failure. Pacing Clin Electrophysiol 2009; 32: 363-370.
9. Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: Results from PARTNERS HF (Program to Access and Review Trending information and Evaluate correlation to Symptoms in patients with Heart Failure) study. J Am Coll Cardiol 2010; 55: 1803-1810.
10. Conraads VM, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM, Cowie MR,. Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations. Eur Heart J 2011; 32: 2266-2273.
11. Wang L,. Key lessons from cases worldwide. Am J Cardiol 2007; 99: 34G-40G.
12. Small RS,. Integrating device-based monitoring into clinical practice: Insights from a large heart failure clinic. Am J Cardiol 2007; 99: 17G-22G.
13. Van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, Kautzner J, et al. Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 2011; 124: 1719-1726.
14. Moore HJ, Peters MN, Franz MR, Karasik PE, Singh SN, Fletcher RD,. Intrathoracic impedance preceding ventricular tachyarrhythmia episodes. Pacing Clin Electrophysiol 2010; 33: 960-966.
15. Ip JE, Cheun JW, Park D, Hellawell, JL, Stein KM, Iwai S, Liu CF, et al. Temporal associations between thoracic volume overload and malignant ventricular arrhythmias: A study of intrathoracic impedance. J Cardiovasc Electrophysiol 2011; 22: 293-299.
16. Lipshultz SE, Sleeper LA, Towbin JA, Lowe AM, Orav EJ, Cox GF, Lurie PR, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003; 348: 1647-1655. (Pubitemid 36459470)
17. Hammill SC, Kremers MS, Stevenson LW, Heidenreich PA, Lang CM, Curtis JP, Wang Y, et al. Review of the Registry's Fourth Year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure. Heart Rhythm 2010; 7: 1349-1345.
18. Burns KM, Evans F, Kaltman JR,. Pediatric ICD utilization in the United States from 1997 to 2006. Heart Rhythm 2011; 8: 23-28.
19. Berul CI, Van Hare GF, Kertesz NJ, Dubin AM, Cecchin F, Collins KK, Cannon BC, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008; 51: 1685-1691.
20. Von Bergen NH, Atkins DL, Dick M 2nd, Bradley DJ, Etheridge SP, Saaral EV, Fischbach PS, et al. Multicenter study of the effectiveness of implantable cardioverter defibrillators in children and young adults with heart disease. Pediatr Cardiol 2011; 32: 399-405.
21. Webster G, Zhang J, Rosenthal D,. Comparison of the epidemiology and co-morbidities of heart failure in the pediatric and adult populations: A retrospective, cross-sectional study. BMC Cardiovasc Disord 2006; 6: 23-30.
22. Sarkar S, Hettrick DA, Koehler J, Rogers T, Gringerg Y, Yu C-M, Abraham WT, et al. Improved algorithm to detect fluid accumulation via intrathoracic impedance monitoring in heart failure patients with implantable devices. J Cardiac Failure 2011; 17: 569-576.